Company Search:
Advanced Search
Sponsored Links
Exelixis, Inc. Company Snapshot
Exelixis, Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Exelixis with three other companies in this sector in UNITED STATES : SAGE Therapeutics Inc (2020 sales of $1.11 billion of which 100% was Biopharmaceuticals), Medpace Holdings Inc ($925.93 million of which 100% was L RESEARCH), and Moderna Inc ($803.40 million of which 100% was BIOLOGICAL PRODUCTS).

Sales Analysis. Exelixis reported sales of $987.54 million for the year ending December of 2020. This represents an increase of 2.0% versus 2019, when the company's sales were $967.78 million. Sales at Exelixis have increased during each of the previous five years (and since 2015, sales have increased a total of 2,557%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Exelixis, Inc.
  Stock Performance Chart for Exelixis, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 24.62
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks 6.5%  
4 Weeks 10.9%   52 Weeks 2.2%  
Exelixis, Inc. Key Data:
  Ticker: EXEL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Commercial Physical Research
  2020 Sales 987,538,000
(Year Ending Jan 2021).
Employees: 773
  Currency: U.S. Dollars Market Cap: 7,672,256,740
  Fiscal Yr Ends: December Shares Outstanding: 311,627,000
  Share Type: Common Closely Held Shares: 5,779,530
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.